Kwality Pharmaceuticals Limited reported earnings results for the second quarter and six months ended September 30, 2022. For the second quarter, the company reported sales was INR 558.05 million compared to INR 1,837.38 million a year ago. Revenue was INR 569.34 million compared to INR 1,838.55 million a year ago. Net income was INR 93.92 million compared to INR 596 million a year ago. Basic earnings per share from continuing operations was INR 8.82 compared to INR 57.33 a year ago. Diluted earnings per share from continuing operations was INR 8.82 compared to INR 57.33 a year ago.
For the six months, sales was INR 1,260.24 million compared to INR 3,039.5 million a year ago. Revenue was INR 1,271.53 million compared to INR 3,050.23 million a year ago. Net income was INR 195.64 million compared to INR 939.73 million a year ago. Basic earnings per share from continuing operations was INR 18.56 compared to INR 90.29 a year ago. Diluted earnings per share from continuing operations was INR 18.56 compared to INR 90.29 a year ago.